rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
26
|
pubmed:dateCreated |
1999-8-13
|
pubmed:abstractText |
This clinical study aimed to clarify the effectiveness and indication of adjuvant hepatic arterial infusion chemotherapy (HAIC) that is performed to prevent recurrence after radical hepatectomy for hepatocellular carcinoma (HCC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0172-6390
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1042-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10370664-Adult,
pubmed-meshheading:10370664-Aged,
pubmed-meshheading:10370664-Aged, 80 and over,
pubmed-meshheading:10370664-Antineoplastic Agents,
pubmed-meshheading:10370664-Carcinoma, Hepatocellular,
pubmed-meshheading:10370664-Chemotherapy, Adjuvant,
pubmed-meshheading:10370664-Combined Modality Therapy,
pubmed-meshheading:10370664-Dose-Response Relationship, Drug,
pubmed-meshheading:10370664-Doxorubicin,
pubmed-meshheading:10370664-Drug Administration Schedule,
pubmed-meshheading:10370664-Female,
pubmed-meshheading:10370664-Follow-Up Studies,
pubmed-meshheading:10370664-Hepatectomy,
pubmed-meshheading:10370664-Humans,
pubmed-meshheading:10370664-Infusions, Intra-Arterial,
pubmed-meshheading:10370664-Iodized Oil,
pubmed-meshheading:10370664-Liver Function Tests,
pubmed-meshheading:10370664-Male,
pubmed-meshheading:10370664-Middle Aged,
pubmed-meshheading:10370664-Survival Rate,
pubmed-meshheading:10370664-Treatment Outcome
|
pubmed:articleTitle |
Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
|
pubmed:affiliation |
Second Department of Surgery, Hiroshima University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|